Ebselen analogues reduce 2-chloroethyl ethyl sulphide toxicity in A-431 cells

Arhiv za Higijenu Rada i Toksikologiju

Volumn 64, Issue 1, 2013, Pages 77-86

  Pino, Maria A ^a,b   Pietka Ottlik, Magdalena ^c   Billack, Blase ^a  

^a ST JOHN'S UNIVERSITY   (United States)

^b Touro College of Osteopathic Medicine   (United States)

^c WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

CEES; Cell viability; EB 1; EB 2; EB 3; EB 4; Human epidermoid carcinoma cells; MTT test; Organoselenium; Pterostilbene; Resveratrol; Vesicant countermeasure

Indexed keywords

2 CHLOROETHYL ETHYL SULPHIDE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; EBSELEN; EBSELEN 2; EBSELEN 3; EBSELEN 4; MUSTARD GAS; RESVERATROL; STILBENE; UNCLASSIFIED DRUG; 2-CHLOROETHYL ETHYL SULFIDE; ANTIOXIDANT; CHEMICAL WARFARE AGENT; ORGANOSELENIUM DERIVATIVE; PROTECTIVE AGENT; PTEROSTILBENE; PYRROLE DERIVATIVE; STILBENE DERIVATIVE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; HUMAN; HUMAN CELL; INCUBATION TIME; SQUAMOUS CELL CARCINOMA; ANALOGS AND DERIVATIVES; CELL SURVIVAL; DRUG EFFECTS; OXIDATIVE STRESS; PATHOLOGY; TUMOR CELL LINE;

ANTIOXIDANTS; AZOLES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; CHEMICAL WARFARE AGENTS; HUMANS; MUSTARD GAS; ORGANOSELENIUM COMPOUNDS; OXIDATIVE STRESS; PROTECTIVE AGENTS; STILBENES;

EID: 84877985523     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/10004-1254-64-2012-2189     Document Type: Article

References (44)

1. Le HQ, Knudsen SJ. Exposure to a First World War blistering agent. Emerg Med J 2006;23:296-9.
2. Schmidt A, Bölck B, Jedig M, Steinritz D, Balszuweit F, Kehe K, Bloch W. Nitrogen mustard (Chlorambucil) has a negative infl uence on early vascular development. Toxicology 2009;263:32-40.
3. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for sulfur mustards. Atlanta (GA): US Department of Health and Human Services, Public Health Service; 2007.
4. Gross CL, Innace JK, Hovatter RC, Meier HL, Smith WJ. Biochemical manipulation of intracellular glutathione levels infl uences cytotoxicity to isolated human lymphocytes by sulfur mustard. Cell Biol Toxicol 1993;9:259-67.
5. Korkmaz A, Yaren H, Topal T, Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch Toxicol 2006;80:662-70.
6. Paromov V, Qui M, Yang H, Smith M, Stone WL. The infl uence of N-acetyl-L-cysteine on oxidative stress and nitric oxide synthesis in stimulated macrophages treated with a mustard gas analogue. BMC Cell Biol 2008;9:33. doi:10.1186/1471-2121-9-33
7. Ucar M, Korkmaz A, Reiter RJ, Yaren H, oter S, Kurt B, Topal T. Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol Lett 2007;173:124-31.
8. McClintock SD, Hoesel LM, Das SK, Till GO, Neff T, Kunkel RG, Smith mg, Ward PA. Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J Appl Toxicol 2006;26:126-31.
9. Hardej D, Billack B. Ebselen protects brain, skin, lung, and blood cells from mechlorethamine toxicity. Toxicol Ind Health 2007;23:209-21.
10. Holl V, Coelho D, Silbernagel L, Keyser JF, Waltzinger C, Dufour P, Bischoff PL. Prevention of nitrogen mustardinduced apoptosis in normal and transformed lymphocytes by ebselen. Biochem Pharmacol 2000;60:1565-77.
11. Khan S, Ramwani JJ, O'Brien PJ. Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugs. Role of lipid peroxidation. Biochem Pharmacol 1992;43:1963-7.
12. Pino MA, Billack B. Reduction of vesicant toxicity by butylated hydroxyanisole in A-431 skin cells. Cutan Ocul Toxicol 2008;27:161-72.
13. Mugesh G, du Mont W, Sies H. Chemistry of biologically important synthetic organoselenium compounds. Chem Rev 2001;101:2125-79.
14. Bhabak K, Mugesh G. Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants. Acc Chem Res 2010;43:1408-19.
15. Kanda N, Watanabe S. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431. J Invest Dermatol 2002;119:1080-9.
16. Lazarova Z, Domloge-Hultsch N, Yancey KB. Epiligrin is decreased in papulonodular basal cell carcinoma tumor nest basement membranes and the extracellular matrix of transformed human epithelial cells. Exp Dermatol 1995;4:121-9.
17. Radkar V, Hardej D, Lau-Cam C, Billack B. Evaluation of resveratrol and piceatannol cytoxicity in macrophages, T cells, and skin cells. Arh Hig Rada Toksikol 2007;58:292-304.
18. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973;51:1417-23.
19. Wójtowicz H, Kloc K, Maliszewska I, Młochowski J, Pietka M, Piasecki E. Azaanalogues of ebselen as antimicrobial and antiviral agents: synthesis and properties. Farmaco 2004;59:863-8.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
21. Shah SJ, Sylvester PW. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp Biol Med (Maywood) 2005;230:235-41.
22. Ghose AK, Viswanadhan VN, Wendoloski JJ. Prediction of hydrophobic (Lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods. J Phys Chem A 1998;102:3762-72.
23. Graham JS, Stevenson RS, Mitcheltree LW, Hamilton TA, Deckert RR, Lee RB, Schiavetta AM. Medical management of cutaneous sulfur mustard injuries. Toxicology 2009;263:47-58.
24. Saladi RN, Smith E, Persaud AN. Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol 2006;31:1-5.
25. Bhat KR, Benton BJ, Rosenthal DS, Smulson ME, Ray R. Role of poly(ADP-ribose) polymerase (PARP) in DNA repair in sulfur mustard-exposed normal human epidermal keratinocytes (NHEK). J Appl Toxicol 2000;20(Suppl 1): S13-7.
26. Kehe K, Balszuweit F, Steinritz D, Thiermann H. Molecular toxicology of sulfur mustard-induced cutaneous infl ammation and blistering. Toxicology 2009;263:12-9.
27. Gordon MK, Desantis A, Deshmukh M, Lacey CJ, Hahn RA, Beloni J, Anumolu SS, Schlager JJ, Gallo MA, Gerecke DR, Heindel ND, Svoboda KK, Babin MC, Sinko PJ. Doxycycline hydrogels as a potential therapy for ocular vesicant injury. J Ocul Pharmacol Ther 2010;26:407-19.
28. Jain AK, Tewari-Singh N, Gu M, Inturi S, White CW, Agarwal R. Sulfur mustard analog, 2-chloroethyl ethyl sulfide-induced skin injury involves DNA damage and induction of infl ammatory mediators, in part via oxidative stress, in SKH-1 hairless mouse skin. Toxicol Lett 2011;205:293-301.
29. Giocanti N, Hennequin C, Rouillard D, Defrance R, Favaudon V. Additive interaction of gefitinib ('Iressa', ZD1839) and ionising radiation in human tumour cells in vitro. Br J Cancer 2004;91:2026-33.
30. Reiss M, Brash DE, Muñoz-Antonia T, Simon JA, Ziegler A, Vellucci VF, Zhou ZL. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines. Oncol Res 1992;4:349-57.
31. Pereko T, Janncinova V, Drabikova K, Nosal R, Harmatha J. Structure-efficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene. Neuro Endocrinol Lett 2008;29:802-5.
32. Tripathi DN, Jena GB. Ebselen attenuates cyclophosphamideinduced oxidative stress and DNA damage in mice. Free Radic Res 2008;42:966-77.
33. Wagner G, Schuch G, Akerboom TP, Sies H. Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte. Biochem Pharmacol 1994;48:1137-44.
34. Sies H, Cadenas E. Oxidative stress: damage to intact cells and organs. Philos Trans R Soc Lond B Biol Sci 1985;311:617-31.
35. Nozawa R, Arai M, Kuruto R, Motohashi T, Masayasu H. Susceptibility of mice to bacterial and fungal infections after intragastric administration of ebselen. J Pharm Pharmacol 1996;8:64-7.
36. Masumoto H, Sies H. The reaction of ebselen with peroxynitrite. Chem Res Toxicol 1996;9:262-7.
37. Bien M, Blaszczyk B, Kalinowska K, mLochowski J, Inglot AD. Anitfungal activity of 2-(4-chlorophenyl)-1.2 benzisoselenazol-3(2H)-one, the analog of Ebselen. Arch Immunol Ther Exp (Warsz)1999;47:185-93.
38. Wojtowicz H, Chojnacka M, mLochowski J, Palus J, Syper L, Hudcova D. Functionalized alkyl and aryl diselenides as antimicrobial and antiviral agents: synthesis and properties. Il Farmaco 2003;58:1235-42.
39. Pietka-Ottlik M, Wojtowicz-Mlochowska H, Kolodziejczyk K, Piasecki E, mLochowski J. New organoselenium compounds active against pathogenic bacteria, fungi and viruses, Chem Pharm Bull (Tokyo) 2008;56:1423-7.
40. Olm E, Jönsson-Videsäter K, Ribera-Cortada I, Fernandes AP, Eriksson LC, Lehmann S, Rundlöf AK, Paul C, Björnstedt M. Selenite is a potent cytotoxic agent for human primary AML cells. Cancer Lett 2009;282:116-23.
41. Funk D, Schrenk HH, Frei E. Serum albumin leads to falsepositive results in the XTT and the MTT assay. Biotechniques 2007;43:178-86.
42. Schröterová L, Králová V, Vorá cová A, Hasková P, Rudolf E, Cervinka M. Antiproliferative effects of selenium compounds in colon cancer cells: comparison of different cytotoxicity assays. Toxicol In Vitro 2009;23:1406-11.
43. Kim SJ, Park C, Han AL, Youn MJ, Lee JH, Kim Y, Kim ES, Kim HJ, Kim JK, Lee HK, Chung SY, So H, Park R. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells. Hear Res 2009;251:70-82.
44. Ursini F, Bindoli A. The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem Phys Lipids 1987;44:255-76.